GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axogen Inc (LTS:0HKD) » Definitions » Cyclically Adjusted Price-to-FCF

Axogen (LTS:0HKD) Cyclically Adjusted Price-to-FCF : (As of Apr. 30, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Axogen Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Axogen Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Axogen's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axogen Cyclically Adjusted Price-to-FCF Chart

Axogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Axogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Axogen's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Axogen's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axogen's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Axogen's Cyclically Adjusted Price-to-FCF falls into.



Axogen Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Axogen's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Axogen's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.046/129.4194*129.4194
=-0.046

Current CPI (Dec. 2023) = 129.4194.

Axogen Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.193 99.695 -0.251
201406 -0.153 100.560 -0.197
201409 -0.136 100.428 -0.175
201412 -0.142 99.070 -0.186
201503 -0.113 99.621 -0.147
201506 -0.146 100.684 -0.188
201509 -0.113 100.392 -0.146
201512 -0.146 99.792 -0.189
201603 -0.170 100.470 -0.219
201606 -0.095 101.688 -0.121
201609 -0.086 101.861 -0.109
201612 -0.057 101.863 -0.072
201703 -0.125 102.862 -0.157
201706 -0.073 103.349 -0.091
201709 -0.073 104.136 -0.091
201712 -0.046 104.011 -0.057
201803 -0.184 105.290 -0.226
201806 -0.122 106.317 -0.149
201809 -0.219 106.507 -0.266
201812 -0.134 105.998 -0.164
201903 -0.240 107.251 -0.290
201906 -0.186 108.070 -0.223
201909 -0.101 108.329 -0.121
201912 -0.114 108.420 -0.136
202003 -0.332 108.902 -0.395
202006 -0.384 108.767 -0.457
202009 -0.082 109.815 -0.097
202012 -0.011 109.897 -0.013
202103 -0.346 111.754 -0.401
202106 -0.221 114.631 -0.250
202109 -0.240 115.734 -0.268
202112 -0.210 117.630 -0.231
202203 -0.399 121.301 -0.426
202206 -0.238 125.017 -0.246
202209 -0.124 125.227 -0.128
202212 -0.128 125.222 -0.132
202303 -0.281 127.348 -0.286
202306 -0.102 128.729 -0.103
202309 -0.053 129.860 -0.053
202312 -0.046 129.419 -0.046

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Axogen  (LTS:0HKD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Axogen Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Axogen's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Axogen (LTS:0HKD) Business Description

Traded in Other Exchanges
Address
13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Axogen (LTS:0HKD) Headlines

No Headlines